Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma.
about
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review.Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort.18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanomaThe future of immunotherapy for sarcoma.Peptide vaccination therapy: Towards the next generation.T cell exhaustion: from pathophysiological basics to tumor immunotherapy.Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review.Immune-related musculoskeletal toxicities among cancer patients treated with immune checkpoint inhibitors: a systematic review.Surrogate end points for overall survival in trials of PD-(L)1 inhibitors for urinary cancers: a systematic review.Trial watch: Immune checkpoint blockers for cancer therapy.Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review.CME Part 1: Hair disorders in cancer patients.
P2860
Q30235360-8DF79907-3F1C-4DC6-A28C-862E345728A7Q37606693-A63242D5-ADBD-4998-A7D1-19860151D9CDQ38663172-74C14FC0-646B-4818-8081-3319D38CC8BCQ38829558-389EC131-BE0D-4927-8189-108E56456FD1Q38902336-4D0DF61E-4C49-460C-B6B4-8D17FECA6F54Q39078341-CEFEE2BC-143A-4C8A-B261-3A960C4B0B66Q39332694-8BED688C-79FC-4670-B05E-9215CFD009E0Q46694815-3D8EBC77-7A9B-4EDD-9319-4EED0C9087FCQ47278600-FFA67002-125D-48CF-AA1B-91F068BD6FEEQ47393365-9E573286-48CE-4AC8-A868-55F27BF44A01Q47705923-EDB4D709-839C-41A2-8DC9-4C93CB02AF74Q47747375-CE7E3AB6-13FC-4BBF-89DB-92E66685D4F6Q52585556-2F546348-C9B2-402D-9E40-66E27D97D21F
P2860
Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma.
@ast
Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma.
@en
type
label
Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma.
@ast
Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma.
@en
prefLabel
Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma.
@ast
Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma.
@en
P2093
P2860
P1476
Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma.
@en
P2093
A Tsutsumida
N Shibagaki
N Yamazaki
S Fukushima
S Yoshikawa
T Tokudome
P2860
P2888
P304
P356
10.1007/S00280-015-2873-X
P577
2015-09-26T00:00:00Z